Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Paulzen

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Clinical Pharmacokinetics|September 4, 2017
Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of VenlafaxineMaxim Kuzin, Georgios Schoretsanitis, Ekkehard Haen, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 4, 2016
Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patternsMichael Paulzen, Ekkehard Haen, Benedikt Stegmann, et al.
Basic & Clinical Pharmacology & Toxicology|April 21, 2020
Pharmacokinetic interactions between clozapine and sertraline in smokers and non-smokersMaxim Kuzin, Georgios Schoretsanitis, Ekkehard Haen, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 3, 2020
The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysisGeorgios Schoretsanitis, Olav Spigset, Julia C Stingl, et al.
Psychopharmacology|May 3, 2018
The role of striatal dopamine D<sub>2/3</sub> receptors in cognitive performance in drug-free patients with schizophreniaTanja Veselinović, Ingo Vernaleken, Hildegard Janouschek, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2020
Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysisGeorgios Schoretsanitis, Andreas A Westin, Julia C Stingl, et al.
British Journal of Clinical Pharmacology|February 5, 2017
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacyMichael Paulzen, Ekkehard Haen, Christoph Hiemke, et al.
Clinical Pharmacokinetics|September 27, 2018
Comprehensive Measurements of Intrauterine and Postnatal Exposure to LamotrigineMichael Paulzen, Julia C Stingl, Marc Augustin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 21, 2017
Pharmacokinetics of risperidone in different application forms - Comparing long-acting injectable and oral formulationsGeorgios Schoretsanitis, Jose de Leon, Ekkehard Haen, et al.
Expert Review of Clinical Pharmacology|March 31, 2025
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysisNele Römer, Arnim Johannes Gaebler, Irene Neuner, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|September 4, 2017
Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of VenlafaxineMaxim Kuzin, Georgios Schoretsanitis, Ekkehard Haen, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 4, 2016
Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patternsMichael Paulzen, Ekkehard Haen, Benedikt Stegmann, et al.
Basic & Clinical Pharmacology & Toxicology|April 21, 2020
Pharmacokinetic interactions between clozapine and sertraline in smokers and non-smokersMaxim Kuzin, Georgios Schoretsanitis, Ekkehard Haen, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 3, 2020
The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysisGeorgios Schoretsanitis, Olav Spigset, Julia C Stingl, et al.
Psychopharmacology|May 3, 2018
The role of striatal dopamine D<sub>2/3</sub> receptors in cognitive performance in drug-free patients with schizophreniaTanja Veselinović, Ingo Vernaleken, Hildegard Janouschek, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2020
Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysisGeorgios Schoretsanitis, Andreas A Westin, Julia C Stingl, et al.
British Journal of Clinical Pharmacology|February 5, 2017
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacyMichael Paulzen, Ekkehard Haen, Christoph Hiemke, et al.
Clinical Pharmacokinetics|September 27, 2018
Comprehensive Measurements of Intrauterine and Postnatal Exposure to LamotrigineMichael Paulzen, Julia C Stingl, Marc Augustin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 21, 2017
Pharmacokinetics of risperidone in different application forms - Comparing long-acting injectable and oral formulationsGeorgios Schoretsanitis, Jose de Leon, Ekkehard Haen, et al.
Expert Review of Clinical Pharmacology|March 31, 2025
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysisNele Römer, Arnim Johannes Gaebler, Irene Neuner, et al.
Pageof 10